{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:38:33Z","timestamp":1790804313394,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,1,5]],"date-time":"2017-01-05T00:00:00Z","timestamp":1483574400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,1,5]],"date-time":"2017-01-05T00:00:00Z","timestamp":1483574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Intrinsically disordered proteins (IDPs) are prevalent in eukaryotes, performing signaling and regulatory functions. Often associated with human diseases, they constitute drug-development targets. NUPR1 is a multifunctional IDP, over-expressed and involved in pancreatic ductal adenocarcinoma (PDAC) development. By screening 1120 FDA-approved compounds, fifteen candidates were selected, and their interactions with NUPR1 were characterized by experimental and simulation techniques. The protein remained disordered upon binding to all fifteen candidates. These compounds were tested in PDAC-derived cell-based assays, and all induced cell-growth arrest and senescence, reduced cell migration, and decreased chemoresistance, mimicking NUPR1-deficiency. The most effective compound completely arrested tumor development<jats:italic>in vivo<\/jats:italic>on xenografted PDAC-derived cells in mice. Besides reporting the discovery of a compound targeting an intact IDP and specifically active against PDAC, our study proves the possibility to target the \u2018fuzzy\u2019 interface of a protein that remains disordered upon binding to its natural biological partners or to selected drugs.<\/jats:p>","DOI":"10.1038\/srep39732","type":"journal-article","created":{"date-parts":[[2017,1,5]],"date-time":"2017-01-05T10:37:22Z","timestamp":1483612642000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":131,"title":["Identification of a Drug Targeting an Intrinsically Disordered Protein Involved in Pancreatic Adenocarcinoma"],"prefix":"10.1038","volume":"7","author":[{"given":"Jos\u00e9 L.","family":"Neira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Bintz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Arruebo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Rizzuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Bonacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Lanas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri\u00e1n","family":"Vel\u00e1zquez-Campoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan L.","family":"Iovanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Abi\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,5]]},"reference":[{"key":"BFsrep39732_CR1","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/nrd2132","volume":"5","author":"P Imming","year":"2006","unstructured":"Imming, P., Sinnin, C. & Meyer, A. Drugs, their targets and the nature and number of drug targets. Nat. Rev. Drug Discov. 5, 821\u2013834 (2006).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFsrep39732_CR2","doi-asserted-by":"crossref","unstructured":"H\u00fcser, J. High-throughput screening in drug discovery. In: Methods and Principles in Medicinal Chemistry, Vol. 35 (Wiley-VCH, 2006).","DOI":"10.1002\/3527609326"},{"key":"BFsrep39732_CR3","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/nature06526","volume":"450","author":"JA Wells","year":"2007","unstructured":"Wells, J. A. & McClendon, C. L. Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature 450, 1001\u20131009 (2007).","journal-title":"Nature"},{"key":"BFsrep39732_CR4","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/pro.2261","volume":"22","author":"VN Uversky","year":"2013","unstructured":"Uversky, V. N. A decade and a half of protein intrinsic disorder: biology still waits for biophysics. Protein Sci. 22, 693\u2013724 (2013).","journal-title":"Protein Sci."},{"key":"BFsrep39732_CR5","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.tibs.2012.08.004","volume":"37","author":"P Tompa","year":"2012","unstructured":"Tompa, P. Intrinsically disordered proteins: a 10-year recap. Trends Biochem. Sci. 37, 509\u2013516 (2012).","journal-title":"Trends Biochem. Sci."},{"key":"BFsrep39732_CR6","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/pro.2450","volume":"23","author":"Y Huang","year":"2014","unstructured":"Huang, Y. & Liu, Z. Advantages of proteins being disordered. Protein Sci. 23, 539\u2013550 (2014).","journal-title":"Protein Sci."},{"key":"BFsrep39732_CR7","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.drudis.2013.04.008","volume":"18","author":"WL Tou","year":"2013","unstructured":"Tou, W. L. & Chen, C. Y. H. How to design a drug for the disordered proteins? Drug Discov. Today 18, 910\u2013915 (2013).","journal-title":"Drug Discov. Today"},{"key":"BFsrep39732_CR8","doi-asserted-by":"publisher","first-page":"32360","DOI":"10.1074\/jbc.272.51.32360","volume":"272","author":"GV Mallo","year":"1997","unstructured":"Mallo, G. V. et al. Cloning and expression of the rat p8 cDNA, a new gene activated in pancreas during the acute phase of pancreatitis, pancreatic development and regeneration, and which promotes cellular growth. J. Biol. Chem. 272, 32360\u201332369 (1997).","journal-title":"J. Biol. Chem."},{"key":"BFsrep39732_CR9","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1074\/jbc.M008594200","volume":"276","author":"JA Encinar","year":"2001","unstructured":"Encinar, J. A. et al. Human p8 is a HMG-I\/Y-like protein with DNA binding activity enhanced by phosphorylation. J. Biol. Chem. 276, 2742\u20132751 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFsrep39732_CR10","doi-asserted-by":"publisher","first-page":"3442","DOI":"10.1002\/jcp.22702","volume":"226","author":"MJ Sandi","year":"2011","unstructured":"Sandi, M. J. et al. p8 expression controls pancreatic cell migration, invasion, adhesion, and tumorigenesis. J. Cell. Physiol. 226, 3442\u20133451 (2011).","journal-title":"J. Cell. Physiol."},{"key":"BFsrep39732_CR11","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1172\/JCI60144","volume":"122","author":"T Hamidi","year":"2012","unstructured":"Hamidi, T. et al. Nuclear protein 1 promotes pancreatic cancer development and protects cells from stress by inhibiting apoptosis. J. Clin. Invest. 122, 2092\u20132103 (2012).","journal-title":"J. Clin. Invest."},{"key":"BFsrep39732_CR12","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1002\/jcp.22324","volume":"226","author":"CE Cano","year":"2011","unstructured":"Cano, C. E., Hamidi, T., Sandi, M. J. & Iovanna, J. L. Nupr1: the Swiss-knife to cancer. J. Cell. Physiol. 226, 1439\u20131443 (2011).","journal-title":"J. Cell. Physiol."},{"key":"BFsrep39732_CR13","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1074\/jbc.R109.080887","volume":"285","author":"S Goruppi","year":"2010","unstructured":"Goruppi, S. & Iovanna, J. L. Stress-inducible protein p8 is involved in several physiological and pathological processes. J. Biol. Chem. 285, 1577\u20131581 (2010).","journal-title":"J. Biol. Chem."},{"key":"BFsrep39732_CR14","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1073\/pnas.0508955103","volume":"103","author":"C Malicet","year":"2006","unstructured":"Malicet, C. et al. Regulation of apoptosis by the p8\/prothymosin alpha complex. Proc. Natl. Acad. Sci. USA 103, 2671\u20132676 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFsrep39732_CR15","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1158\/1078-0432.CCR-05-1700","volume":"12","author":"V Giroux","year":"2006","unstructured":"Giroux, V. et al. p8 is a new target of gemcitabine in pancreatic cancer cells. Clin. Cancer Res. 12, 235\u2013241 (2006).","journal-title":"Clin. Cancer Res."},{"key":"BFsrep39732_CR16","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1038\/cdd.2014.74","volume":"21","author":"D Grasso","year":"2014","unstructured":"Grasso, D. et al. Genetic inactivation of the pancreatitis-inducible gene Nupr1 impairs PanIN formation by modulating Kras(G12D)-induced senescence. Cell Death Differ. 21, 1633\u20131641 (2014).","journal-title":"Cell Death Differ"},{"key":"BFsrep39732_CR17","doi-asserted-by":"publisher","first-page":"5234","DOI":"10.1158\/1078-0432.CCR-12-0026","volume":"18","author":"T Hamidi","year":"2012","unstructured":"Hamidi, T. et al. Nupr1-aurora kinase A pathway provides protection against metabolic stress-mediated autophagic-associated cell death. Clin. Cancer Res. 18, 5234\u20135246 (2012).","journal-title":"Clin. Cancer Res."},{"key":"BFsrep39732_CR18","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1002\/jcp.21889","volume":"221","author":"M Gironella","year":"2009","unstructured":"Gironella, M. et al. p8\/nupr1 regulates DNA-repair activity after double-strand gamma irradiation-induced DNA damage. J. Cell. Physiol. 221, 594\u2013602 (2009).","journal-title":"J. Cell. Physiol."},{"key":"BFsrep39732_CR19","doi-asserted-by":"publisher","first-page":"e78101","DOI":"10.1371\/journal.pone.0078101","volume":"8","author":"D Aguado-Llera","year":"2013","unstructured":"Aguado-Llera, D. et al. Deciphering the binding between Nupr1 and MSL1 and their DNA-repairing activity. PLoS One 8, e78101 (2013).","journal-title":"PLoS One"},{"key":"BFsrep39732_CR20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.abb.2016.03.034","volume":"598","author":"JL Neira","year":"2016","unstructured":"Neira, J. L., Rizzuti, B. & Iovanna, J. L. Determinants of the pK a values of ionizable residues in an intrinsically disordered protein. Arch. Biochem. Biophys. 598, 18\u201327 (2016).","journal-title":"Arch. Biochem. Biophys."},{"key":"BFsrep39732_CR21","doi-asserted-by":"publisher","first-page":"15686","DOI":"10.1038\/srep15686","volume":"5","author":"LI Iconaru","year":"2015","unstructured":"Iconaru, L. I. et al. Discovery of small molecules that inhibit the disordered protein, p27(Kip1). Sci. Rep. 5, 15686 (2015).","journal-title":"Sci. Rep."},{"key":"BFsrep39732_CR22","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/nchembio.1528","volume":"10","author":"N Krishnan","year":"2014","unstructured":"Krishnan, N. et al. Targeting the disordered C terminus of PTP1B with an allosteric inhibitor. Nat. Chem. Biol. 10, 558\u2013566 (2014).","journal-title":"Nat. Chem. Biol."},{"key":"BFsrep39732_CR23","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0022-2836(82)90515-0","volume":"157","author":"J Kyte","year":"1982","unstructured":"Kyte, J. & Doolittle, R. F. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157, 105\u2013132 (1982).","journal-title":"J. Mol. Biol."},{"key":"BFsrep39732_CR24","doi-asserted-by":"publisher","first-page":"W264","DOI":"10.1093\/nar\/gku270","volume":"42","author":"E Cilia","year":"2014","unstructured":"Cilia, E., Pancsa, R., Tompa, P., Lenaerts, T. & Vranken, W. F. The DynaMine webserver: predicting protein dynamics from sequence. Nucleic Acids Res. 42, W264\u2013W270 (2014).","journal-title":"Nucleic Acids Res"},{"key":"BFsrep39732_CR25","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1038\/ncomms3741","volume":"4","author":"E Cilia","year":"2013","unstructured":"Cilia, E., Pancsa, R., Tompa, P., Lenaerts, T. & Vranken W. F. From protein sequence to dynamics and disorder with DynaMine. Nat. Commun. 4, 2741 (2013).","journal-title":"Nat. Commun."},{"key":"BFsrep39732_CR26","doi-asserted-by":"publisher","first-page":"W460","DOI":"10.1093\/nar\/gkm363","volume":"35","author":"T Ishida","year":"2007","unstructured":"Ishida, T. & Kinoshita, K. PrDOS: prediction of disordered protein regions from amino acid sequence. Nucleic Acids Res. 35, W460\u2013W464 (2007).","journal-title":"Nucleic Acids Res"},{"key":"BFsrep39732_CR27","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1093\/bioinformatics\/btn326","volume":"24","author":"LJ McGuffin","year":"2008","unstructured":"McGuffin, L. J. Intrinsic disorder prediction from the analysis of multiple protein fold recognition models. Bioinformatics 24, 1798\u20131804 (2008).","journal-title":"Bioinformatics"},{"key":"BFsrep39732_CR28","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.jmb.2004.02.002","volume":"337","author":"JJ Ward","year":"2004","unstructured":"Ward, J. J., Sodhi, J. S., McGuffin, L. J., Buxton, B. F. & Jones, D. T. Prediction and functional analysis of native disorder in proteins from the three kingdoms of life. J. Mol. Biol. 337, 635\u2013645 (2004).","journal-title":"J. Mol. Biol."},{"key":"BFsrep39732_CR29","doi-asserted-by":"publisher","first-page":"I75","DOI":"10.1093\/bioinformatics\/bts209","volume":"28","author":"FM Disfani","year":"2012","unstructured":"Disfani, F. M. et al. MoRFpred, a computational tool for sequence-based prediction and characterization of short disorder-to-order transitioning binding regions in proteins. Bioinformatics 28, I75\u2013I83 (2012).","journal-title":"Bioinformatics"},{"key":"BFsrep39732_CR30","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1093\/bioinformatics\/btp518","volume":"25","author":"Z Dosztanyi","year":"2009","unstructured":"Dosztanyi, Z., Meszaros, B. & Simon, I. ANCHOR: web server for predicting protein binding regions in disordered proteins. Bioinformatics 25, 2745\u20132746 (2009).","journal-title":"Bioinformatics"},{"key":"BFsrep39732_CR31","doi-asserted-by":"publisher","first-page":"e1000376","DOI":"10.1371\/journal.pcbi.1000376","volume":"5","author":"B Meszaros","year":"2009","unstructured":"Meszaros, B., Simon, I. & Dosztanyi, Z. Prediction of protein binding regions in disordered proteins. PLoS Comput. Biol. 5, e1000376 (2009).","journal-title":"PLoS Comput. Biol."},{"key":"BFsrep39732_CR32","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.tibtech.2006.07.005","volume":"24","author":"Y Cheng","year":"2006","unstructured":"Cheng, Y. et al. Rational drug design via intrinsically unfolded protein. Trends Biotechnol. 24, 435\u2013442 (2006).","journal-title":"Trends Biotechnol."},{"key":"BFsrep39732_CR33","doi-asserted-by":"publisher","first-page":"e87133","DOI":"10.1371\/journal.pone.0087133","volume":"9","author":"G Toth","year":"2014","unstructured":"Toth, G. et al. Targeting the intrinsically disordered structural ensemble of \u03b1-synuclein by small molecules as a potential therapeutic strategy for Parkinson\u2019s disease. PLoS One 9, e87133 (2014).","journal-title":"PLoS One"},{"key":"BFsrep39732_CR34","doi-asserted-by":"publisher","first-page":"7390","DOI":"10.1021\/ja900616b","volume":"131","author":"DI Hammoudeth","year":"2009","unstructured":"Hammoudeth, D. I., Follis, A. V., Prochwonik, E. V. & Metallo, S. V. Multiple binding sites for small-molecule inhibitors on the oncoprotein c-Myc. J. Am. Chem. Soc. 131, 7390\u20137401 (2009).","journal-title":"J. Am. Chem. Soc."},{"key":"BFsrep39732_CR35","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.chembiol.2008.09.011","volume":"15","author":"AV Follis","year":"2008","unstructured":"Follis, A. V., Hammoudeth, D. I., Wang, H., Prochwonik, E. V. & Metallo, S. V. Structural rationale for the coupled binding and unfolding of the c-Myc oncoprotein by small molecules. Chem. Biol. 15, 1149\u20131155 (2008).","journal-title":"Chem. Biol."},{"key":"BFsrep39732_CR36","doi-asserted-by":"publisher","first-page":"e69773","DOI":"10.1371\/journal.pone.0069773","volume":"8","author":"O Abian","year":"2013","unstructured":"Abian, O., Vega, S., Sancho, J. & Velazquez-Campoy, A. Allosteric inhibitors of the NS3 protease from the Hepatitis C Virus. PLoS One 8, e69773 (2013).","journal-title":"PLoS One"},{"key":"BFsrep39732_CR37","doi-asserted-by":"publisher","first-page":"27540","DOI":"10.1038\/srep27540","volume":"6","author":"CH Wu","year":"2016","unstructured":"Wu, C. H. et al. Pharmacological exploitation of the phenothiazine antipsychotics to develop novel antitumor agents: A drug repurposing strategy. Sci. Rep. 6, 27540 (2016).","journal-title":"Sci. Rep."},{"key":"BFsrep39732_CR38","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1007\/s00894-014-2357-7","volume":"20","author":"R Urrutia","year":"2014","unstructured":"Urrutia, R. et al. Evidence supporting the existence of a NUPR1-like family of helix-loop-helix chromatin proteins related to, yet distinct from, AT hook-containing HMG proteins. J. Mol. Model. 20, 2357 (2014).","journal-title":"J. Mol. Model."},{"key":"BFsrep39732_CR39","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/febs.13631","volume":"283","author":"A Gruet","year":"2016","unstructured":"Gruet, A. et al. Fuzzy regions in an intrinsically disordered protein impair protein-protein interactions. FEBS J. 283, 576\u2013594 (2016).","journal-title":"FEBS J."},{"key":"BFsrep39732_CR40","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1021\/cb900166q","volume":"4","author":"N Cremades","year":"2009","unstructured":"Cremades, N. et al. Discovery of specific flavodoxin inhibitors as potential therapeutic agents against Helicobacter pylori infection. ACS Chem. Biol. 4, 928\u2013938 (2009).","journal-title":"ACS Chem. Biol."},{"key":"BFsrep39732_CR41","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1172\/JCI34355","volume":"118","author":"AL Pey","year":"2008","unstructured":"Pey, A. L. et al. Identification of pharmacological chaperones as potential therapeutic agents to treat phenylketonuria. J. Clin. Invest. 118, 2858\u20132867 (2008).","journal-title":"J. Clin. Invest."},{"key":"BFsrep39732_CR42","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0009-2614(80)80041-8","volume":"69","author":"G Bodenhausen","year":"1980","unstructured":"Bodenhausen, G. & Ruben, D. Natural abundance nitrogen-15 NMR by enhanced heteronuclear spectroscopy. Chem. Phys. Lett. 69, 185\u2013189 (1980).","journal-title":"Chem. Phys. Lett."},{"key":"BFsrep39732_CR43","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/BF02192855","volume":"2","author":"M Piotto","year":"1993","unstructured":"Piotto, M., Saudek, V. & Sklenar, V. Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions. J. Biomol. NMR 2, 661\u2013665 (1993).","journal-title":"J. Biomol. NMR"},{"key":"BFsrep39732_CR44","doi-asserted-by":"publisher","first-page":"12764","DOI":"10.1021\/bi701343q","volume":"46","author":"A Czypionka","year":"2007","unstructured":"Czypionka, A. et al. The isolated C-terminal domain of Ring1B is a dimer made of stable, well-structured monomers. Biochemistry 46, 12764\u201312776 (2007).","journal-title":"Biochemistry"},{"key":"BFsrep39732_CR45","doi-asserted-by":"publisher","first-page":"16424","DOI":"10.1021\/bi991765q","volume":"38","author":"DK Wilkins","year":"1999","unstructured":"Wilkins, D. K. et al. Hydrodynamic radii of native and denatured proteins measured by pulse field gradient NMR techniques. Biochemistry 38, 16424\u201316431 (1999).","journal-title":"Biochemistry"},{"key":"BFsrep39732_CR46","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey, W., Dalke, A. & Schulten, K. VMD. Visual molecular dynamics. J. Mol. Graph. Model. 14, 33\u201338 (1996).","journal-title":"J. Mol. Graph. Model."},{"key":"BFsrep39732_CR47","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera\u2013A visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput. Chem."},{"key":"BFsrep39732_CR48","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","volume":"79","author":"WL Jorgensen","year":"1983","unstructured":"Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W. & Klein, M. L. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79, 926 (1983).","journal-title":"J. Chem. Phys."},{"key":"BFsrep39732_CR49","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1093\/bioinformatics\/btt055","volume":"29","author":"S Pronk","year":"2013","unstructured":"Pronk, S. et al. GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics 29, 845\u2013854 (2013).","journal-title":"Bioinformatics"},{"key":"BFsrep39732_CR50","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1002\/prot.22711","volume":"78","author":"K Lindorff-Larsen","year":"2010","unstructured":"Lindorff-Larsen, K. et al. Improved side-chain torsion potentials for the Amber ff99SB protein force field. Proteins 78, 1950\u20131958 (2010).","journal-title":"Proteins"},{"key":"BFsrep39732_CR51","doi-asserted-by":"publisher","first-page":"10089","DOI":"10.1063\/1.464397","volume":"98","author":"T Darden","year":"1993","unstructured":"Darden, T., York, D. & Pedersen, L. Particle mesh Ewald\u2013an N.Log(N) method for Ewald sums in large systems. J. Chem. Phys. 98, 10089 (1993).","journal-title":"J. Chem. Phys."},{"key":"BFsrep39732_CR52","doi-asserted-by":"publisher","first-page":"8577","DOI":"10.1063\/1.470117","volume":"103","author":"U Essmann","year":"1995","unstructured":"Essmann, U. A smooth particle Mesh Ewald method. J. Chem. Phys. 103, 8577\u20138593 (1995).","journal-title":"J. Chem. Phys."},{"key":"BFsrep39732_CR53","doi-asserted-by":"publisher","first-page":"014101","DOI":"10.1063\/1.2408420","volume":"126","author":"G Bussi","year":"2007","unstructured":"Bussi, G., Donadio, D. & Parrinello, M. Canonical sampling through velocity rescaling. J. Chem. Phys. 126, 014101 (2007).","journal-title":"J. Chem. Phys."},{"key":"BFsrep39732_CR54","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1063\/1.448118","volume":"81","author":"HJC Berendsen","year":"1984","unstructured":"Berendsen, H. J. C., Postma, J. P. M., van Gusteren, W. F., Di Nola, A. & Haak, J. R. Molecular dynamics with coupling to an external bath. J. Chem. Phys. 81, 3684 (1984).","journal-title":"J. Chem. Phys."},{"key":"BFsrep39732_CR55","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott, O. & Olson, A. J. Software news and update AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading. J. Comput. Chem. 31, 455\u2013461 (2010).","journal-title":"J. Comput. Chem."},{"key":"BFsrep39732_CR56","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/jcc.20035","volume":"25","author":"JM Wang","year":"2004","unstructured":"Wang, J. M., Wolf, R. M., Caldwell, J. W., Kollman, P. A. & Case, D. A. Development and testing of a general amber force field. J. Comput. Chem. 25, 1157\u20131174 (2004).","journal-title":"J. Comput. Chem."},{"key":"BFsrep39732_CR57","unstructured":"DeLano, W. L. The PyMOL molecular graphics system. (2002) Available at: http:\/\/www.pymol.org\/."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep39732.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep39732","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep39732.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T15:37:19Z","timestamp":1718984239000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep39732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,5]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,5,2]]}},"alternative-id":["BFsrep39732"],"URL":"https:\/\/doi.org\/10.1038\/srep39732","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,5]]},"assertion":[{"value":"8 June 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39732"}}